Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
De Jaeghere EA, Tuyaerts S, Van Nufel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG. De Jaeghere EA, et al. Among authors: van de vijver kk. Cancer Immunol Immunother. 2024 Dec 30;74(1):32. doi: 10.1007/s00262-024-03873-5. Cancer Immunol Immunother. 2024. PMID: 39738642 Free PMC article. No abstract available.
Etiology, histology, and long-term outcome of bilateral testicular regression: a large Belgian series.
Tack LJW, Brachet C, Beauloye V, Heinrichs C, Boros E, De Waele K, van der Straaten S, Van Aken S, Craen M, Lemay A, Rochtus A, Casteels K, Beckers D, Mouraux T, Logghe K, Van Loocke M, Massa G, Van de Vijver K, Syryn H, Van De Velde J, De Baere E, Verdin H, Cools M. Tack LJW, et al. Among authors: van de vijver k. Hum Reprod Open. 2023 Dec 1;2023(4):hoad047. doi: 10.1093/hropen/hoad047. eCollection 2023. Hum Reprod Open. 2023. PMID: 39659563 Free PMC article.
ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition states.
Verstappe J, Skrypek N, De Coninck J, Soen B, Taminau J, Tatari M, Bruneel K, Loret N, De Clercq K, Van den Broecke C, Van De Vijver K, Van Dorpe J, Haigh J, De Craene B, Goossens S, Vandamme N, Berx G. Verstappe J, et al. Among authors: van de vijver k. iScience. 2024 Oct 16;27(11):111169. doi: 10.1016/j.isci.2024.111169. eCollection 2024 Nov 15. iScience. 2024. PMID: 39555401 Free PMC article.
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
De Jaeghere EA, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel AMT, Baiden-Amissah R, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Verhasselt B, Denys HG. De Jaeghere EA, et al. Among authors: van de vijver kk. Gynecol Oncol. 2024 Dec;191:275-286. doi: 10.1016/j.ygyno.2024.10.020. Epub 2024 Nov 7. Gynecol Oncol. 2024. PMID: 39515198 Clinical Trial.
Assessing the impact of deep-learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes.
Bogaerts JM, Steenbeek MP, Bokhorst JM, van Bommel MH, Abete L, Addante F, Brinkhuis M, Chrzan A, Cordier F, Devouassoux-Shisheboran M, Fernández-Pérez J, Fischer A, Gilks CB, Guerriero A, Jaconi M, Kleijn TG, Kooreman L, Martin S, Milla J, Narducci N, Ntala C, Parkash V, de Pauw C, Rabban JT, Rijstenberg L, Rottscholl R, Staebler A, Van de Vijver K, Zannoni GF, van Zanten M; AI‐STIC Study Group; de Hullu JA, Simons M, van der Laak JA. Bogaerts JM, et al. Among authors: van de vijver k. J Pathol Clin Res. 2024 Nov;10(6):e70006. doi: 10.1002/2056-4538.70006. J Pathol Clin Res. 2024. PMID: 39439213 Free PMC article.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.
Nederlof I, Isaeva OI, de Graaf M, Gielen RCAM, Bakker NAM, Rolfes AL, Garner H, Boeckx B, Traets JJH, Mandjes IAM, de Maaker M, van Brussel T, Chelushkin M, Champanhet E, Lopez-Yurda M, van de Vijver K, van den Berg JG, Hofland I, Klioueva N, Mann RM, Loo CE, van Duijnhoven FH, Skinner V, Luykx S, Kerver E, Kalashnikova E, van Dongen MGJ, Sonke GS, Linn SC, Blank CU, de Visser KE, Salgado R, Wessels LFA, Drukker CA, Schumacher TN, Horlings HM, Lambrechts D, Kok M. Nederlof I, et al. Among authors: van de vijver k. Nat Med. 2024 Nov;30(11):3223-3235. doi: 10.1038/s41591-024-03249-3. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284953 Free PMC article. Clinical Trial.
TRPS1 Is Consistently Expressed in Hidradenoma Papilliferum.
Velthof L, Van Dorpe J, Tummers P, Creytens D, Van de Vijver K. Velthof L, et al. Among authors: van de vijver k. Int J Gynecol Pathol. 2024 Jun 10. doi: 10.1097/PGP.0000000000001042. Online ahead of print. Int J Gynecol Pathol. 2024. PMID: 38959400
211 results